XDH and acute respiratory distress syndrome: A clinical study involving the determination of plasma xanthine and hypoxanthine levels in patients with ARDS demonstrated that both substrates of XO were higher in all patients with ARDS, and plasma hypoxanthine levels were significantly higher in non-survivors of ARDS compared to levels in survivors.